| abstract |
The present invention is (S) -4 - ((2 S, 3 S) -7- carbamoyl-1,1-diethyl-3-methoxy-1,2,3,4-tetrahydronaphthalene-2- Crystalline solid form of monoamino) -2-cyclohexylmethyl-butyric acid. The invention also relates to pharmaceutical compositions comprising such crystalline solid forms, methods of using such crystalline solid forms for the treatment of diseases associated with mu opioid receptor activity, and such crystalline solid forms It provides a method useful in the preparation of the. |